INDOCO REMEDIES
Back to Cashflow Statement
|
INDOCO REMEDIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹157 Cr | ₹179 Cr | ₹174 Cr | ₹82 Cr | ₹123 Cr |
What is the latest Cash Flow from Operating Activities ratio of INDOCO REMEDIES ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹157 Cr |
Mar2023 | ₹179 Cr |
Mar2022 | ₹174 Cr |
Mar2021 | ₹82 Cr |
Mar2020 | ₹123 Cr |
How is Cash Flow from Operating Activities of INDOCO REMEDIES Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹157 Cr | -12.38 | |
Mar2023 | ₹179 Cr | 2.88 | |
Mar2022 | ₹174 Cr | 111.41 | |
Mar2021 | ₹82 Cr | -33.07 | |
Mar2020 | ₹123 Cr | - |
Compare Cash Flow from Operating Activities of peers of INDOCO REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDOCO REMEDIES | ₹2,323.9 Cr | 5.3% | 7.4% | -27.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,971.0 Cr | -7.3% | 1.1% | 15.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,153.0 Cr | -3.5% | 12.9% | 53.4% | Stock Analytics | |
CIPLA | ₹122,717.0 Cr | 0.1% | 9.2% | 6.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,392.0 Cr | -1% | 0.2% | 19.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,702.0 Cr | 3.1% | 9.8% | -7.6% | Stock Analytics |
INDOCO REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDOCO REMEDIES | 5.3% |
7.4% |
-27.5% |
SENSEX | 0.6% |
11% |
10.4% |
You may also like the below Video Courses